NuVasive has plans for expansion and creation of nearly 200 new jobs

By Admin
Nearly 200 new jobs in the medical device manufacturing field could be on the way. According to a new report, NuVasive Manufacturing LLC is making plans...

Nearly 200 new jobs in the medical device manufacturing field could be on the way. According to a new report, NuVasive Manufacturing LLC is making plans for an expansion project that promises to create 195 full-time jobs and generate $9.3 million in annual payroll.

RELATED CONTENT: Medical Device Outsourcing Market Booms

NuVasive Manufacturing LLC is a manufacturing arm of NuVasive Inc, a San Diego-based medical device company specializing in solving back, neck, and leg problems through the creation of “minimally disruptive surgical products and procedures for the spine.” Ohio’s Dayton Daily News reports that NuVasive Manufacturing LLC has just received approval for state assistance if it moves forward with an expansion project in Ohio.

RELATED CONTENT: Why you should invest in the medical device and mHealth market

With that said, the project’s location is by no means set in stone. The report also notes that NuVasive is considering consolidating its manufacturing efforts, moving operations to one centralized location:

San Diego-based NuVasive Inc. is considering consolidating its manufacturing operations. Ohio is competing with Texas and Tennessee for the proposed project. If Ohio were to lose the proposed project, existing jobs in the state could be in jeopardy, state officials said.

RELATED CONTENT: Medical device manufacturers to be hit hard with industry changes

Ohio is one logical choice for the company. NuVasive first moved into Ohio in 2013 with the acquisition of spine implant manufacturer ANC LLC—in changing ANC’s name to NuVasive Manufacturing LLC, the company established roots and full-scale in-house implant manufacturing capabilities in the Dayton area. Dayton Daily News reports that if NuVasive chooses to expand in Ohio, it would be a boon to employment and the economy—to help facilitate the company’s decision, the state’s Tax Credit Authority has offered a 65 percent, seven-year job creation tax credit for the project.

But as the report mentions, NuVasive does have several options. Only time will tell where the manufacturing expansion ends up and where NuVasive will go from here.

[SOURCE: Dayton Daily News]

Share

Featured Articles

Philips Q1 Results hit by $1.1bn Respironics Settlement

As Royal Philips reports Q1 2024 results we profile the Netherlands-based healthcare technology company, who made the switch from consumer electronics

Vaccine Breakthrough on Antibiotics Resistant Diseases

As researchers report breakthrough on vaccine against MRSA bacteria, we look at which pharmas are working on vaccines to combat antimicrobial resistance

Oracle Fusion Cloud Update Boost for Patients

Oracle Fusion Cloud SCM includes new Healthcare Marketplace solution to help hospitals & clinics optimise planning, automate processes and improve outcomes

WHO Tightens air Quality Guidelines as Pollution Kills 7mn

Sustainability

WHO Health Chatbot Built on 'Humanised' GenAI

Digital Healthcare

Costco Weight-Loss Drugs Move Highlights US AOM Growth

Medical Devices & Pharma